CD274 and non-small cell lung carcinoma: In summary, although more prospective data are warranted, we postulated the hypothesis that monitoring TMB, in addition to the existing PD-L1 expression level, could represent the preferable option for future clinical research in the first-line management of advanced non-oncogene-addicted NSCLC patients.